🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study enrolls newly diagnosed unfavorable stage II /stage III-IV class...
Status
Completed
Location
Peking University People's Hospital
Start Date
2019-02-01
Trial ID
NCT07720011
Treatments Being Tested
The purpose of this study is to determine the clinical response to daily In...
Status
Completed
Location
Dermatologic Unit, Ospedale Maggiore Policlinico, Milan, Italy
Start Date
2008-06
Trial ID
NCT01067690
Treatments Being Tested
To compare Overall Survival (OS) for INT230-6 vs United States (US) Standar...
Status
Recruiting
Location
USC/Norris Comprehensive Cancer Center
Start Date
2024-06-28
Trial ID
NCT06263231
Treatments Being Tested
Open label multicentric phase II randomized trial, using high throughput ge...
Status
Active Not Recruiting
Location
Institut de Cancérologie de l'Ouest/Paul Papin
Start Date
2014-04-07
Trial ID
NCT02299999
The addition of targeted immunotherapy will be safe and well tolerated and ...
Status
Recruiting
Location
University of Alabama
Start Date
2022-02-01
Trial ID
NCT05253495
Treatments Being Tested
RATIONALE: Interferon alfa may interfere with the growth of cancer cells. I...
Status
Completed
Location
University of Texas - MD Anderson Cancer Center
Start Date
1995-11
Trial ID
NCT00002882
Ewing's sarcoma and related tumours (ESFT) are rare tumours, with a peak in...
Status
Completed
Location
Chr Felix Guyon
Start Date
2016-12
Trial ID
NCT03011528
The study PNET 5 MB has been designed for children with medulloblastoma of ...
Status
Active Not Recruiting
Location
Medical University of Graz
Start Date
2014-06
Trial ID
NCT02066220
RATIONALE: In this study a combination of anti-cancer drugs (chemotherapy) ...
Status
Active Not Recruiting
Location
Lucile Packard Children's Hospital at Stanford University Medical Center
Start Date
2007-12-17
Trial ID
NCT00602667
Treatments Being Tested
Langerhans cell histiocytosis (LCH) is the most common histiocytic disorder...
Status
Recruiting
Location
West China Second Hospital, Sichuan University
Start Date
2026-02-13
Trial ID
NCT07431060
Treatments Being Tested